跳至主要内容
临床试验/NCT05432154
NCT05432154已完成不适用

Efficacy and Safety of a Novel Silicone Wound Dressing for the Management of Atrophic Vaginitis

Stratpharma AG1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2022年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
Patient-reported Vulvar Quality of Life

研究概览

简要总结

The objective of the study is to determine the efficacy of 7-0940 in the management of atrophic vaginitis in female patients

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
Female
接受健康志愿者
否

入选标准

  • •Able to provide informed consent
  • •Diagnosed acute or chronic Atrophic Vaginitis
  • •Controlled disease, or uncontrolled disease that did not respond to standard therapy with HRT

排除标准

  • •Unable to provide informed consent
  • •Patient unable to apply topical device
  • •Allergy or intolerance to ingredients or excipients of the formulation of studied products
  • •Currently on HRT (orally or topically)
  • •Currently on corticosteroid treatment

研究组 & 干预措施

Treatment arm

Experimental

Patients apply 7-0940 at least 2 times daily for 3 months.

干预措施: Film forming silicone gel (7-0940) (Device)

结局指标

主要结局

Patient-reported Vulvar Quality of Life

时间窗: 3 months

Vulvar Quality of Life Index

次要结局

  • Severity of overall condition(3 months)
  • Patient-reported symptoms(3 months)
  • Product rating(3 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验